Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Rix Brooks

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
The Journal of Biological Chemistry|March 24, 2009
The neuromediator glutamate, through specific substrate interactions, enhances mitochondrial ATP production and reactive oxygen species generation in nonsynaptic brain mitochondriaAlexander Panov, Peter Schonfeld, Sergey Dikalov, et al.
Muscle & Nerve|August 1, 2023
The effects of intervention with intravenous edaravone in Study 19 on hospitalization, tracheostomy, ventilation, and death in patients with amyotrophic lateral sclerosisBenjamin Rix Brooks, Erik P Pioro, Takeshi Sakata, et al.
Drugs in R&D|June 20, 2022
Analysis of the US Safety Data for Edaravone (Radicava<sup>®</sup>) From the Third Year After LaunchAngela Genge, Benjamin Rix Brooks, Björn Oskarsson, et al.
Plos One|June 14, 2022
Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of Study 19 (MCI186-19) [clinical trial NCT01492686]Benjamin Rix Brooks, Terry Heiman-Patterson, Martina Wiedau-Pazos, et al.
The Lancet. Neurology|June 20, 2018
Stage of prolonged survival in ALSBenjamin Rix Brooks, Elena K Bravver, Velma L Langford, et al.
Annals of Neurology|February 5, 2009
Outcomes research in amyotrophic lateral sclerosis: lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education databaseRobert G Miller, Fred Anderson, Benjamin Rix Brooks, et al.
Muscle & Nerve|November 24, 2021
Slowing the loss of physical function in amyotrophic lateral sclerosis with edaravone: Post hoc analysis of ALSFRS-R item scores in pivotal study MCI186-19Benjamin Rix Brooks, Erik P Pioro, Jonathan Katz, et al.
Archives of Physical Medicine and Rehabilitation|February 18, 2010
Power wheelchair prescription, utilization, satisfaction, and cost for patients with amyotrophic lateral sclerosis: preliminary data for evidence-based guidelinesAmber L Ward, Mohammed Sanjak, Kerry Duffy, et al.
Eclinicalmedicine|August 12, 2022
Intravenous edaravone treatment in ALS and survival: An exploratory, retrospective, administrative claims analysisBenjamin Rix Brooks, James D Berry, Malgorzata Ciepielewska, et al.
Archives of Physical Medicine and Rehabilitation|June 20, 2014
Vestibular deficits leading to disequilibrium and falls in ambulatory amyotrophic lateral sclerosisMohammed Sanjak, Mark A Hirsch, Elena K Bravver, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|March 24, 2009
The neuromediator glutamate, through specific substrate interactions, enhances mitochondrial ATP production and reactive oxygen species generation in nonsynaptic brain mitochondriaAlexander Panov, Peter Schonfeld, Sergey Dikalov, et al.
Muscle & Nerve|August 1, 2023
The effects of intervention with intravenous edaravone in Study 19 on hospitalization, tracheostomy, ventilation, and death in patients with amyotrophic lateral sclerosisBenjamin Rix Brooks, Erik P Pioro, Takeshi Sakata, et al.
Drugs in R&D|June 20, 2022
Analysis of the US Safety Data for Edaravone (Radicava<sup>®</sup>) From the Third Year After LaunchAngela Genge, Benjamin Rix Brooks, Björn Oskarsson, et al.
Plos One|June 14, 2022
Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of Study 19 (MCI186-19) [clinical trial NCT01492686]Benjamin Rix Brooks, Terry Heiman-Patterson, Martina Wiedau-Pazos, et al.
The Lancet. Neurology|June 20, 2018
Stage of prolonged survival in ALSBenjamin Rix Brooks, Elena K Bravver, Velma L Langford, et al.
Annals of Neurology|February 5, 2009
Outcomes research in amyotrophic lateral sclerosis: lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education databaseRobert G Miller, Fred Anderson, Benjamin Rix Brooks, et al.
Muscle & Nerve|November 24, 2021
Slowing the loss of physical function in amyotrophic lateral sclerosis with edaravone: Post hoc analysis of ALSFRS-R item scores in pivotal study MCI186-19Benjamin Rix Brooks, Erik P Pioro, Jonathan Katz, et al.
Archives of Physical Medicine and Rehabilitation|February 18, 2010
Power wheelchair prescription, utilization, satisfaction, and cost for patients with amyotrophic lateral sclerosis: preliminary data for evidence-based guidelinesAmber L Ward, Mohammed Sanjak, Kerry Duffy, et al.
Eclinicalmedicine|August 12, 2022
Intravenous edaravone treatment in ALS and survival: An exploratory, retrospective, administrative claims analysisBenjamin Rix Brooks, James D Berry, Malgorzata Ciepielewska, et al.
Archives of Physical Medicine and Rehabilitation|June 20, 2014
Vestibular deficits leading to disequilibrium and falls in ambulatory amyotrophic lateral sclerosisMohammed Sanjak, Mark A Hirsch, Elena K Bravver, et al.
Pageof 5